Updated Jul 16, 2026
Pacheco Rhonda Janice has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Rhonda Janice Pacheco is an executive at Takeda Pharmaceutical Company Limited. Based on the SEC filing dated 2026-07-06, she serves as President of Takeda's U.S. Business Unit, overseeing Takeda's U.S. commercial operations. The available context confirms her role and the company, but does not provide additional background such as education or prior positions.
| Role | President, U.S. Business Unit |
|---|---|
| Notability | 62/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 50.2K | $0.00 |
Rhonda Janice Pacheco is an executive at Takeda Pharmaceutical Company Limited. Based on the SEC filing dated 2026-07-06, she serves as President of Takeda's U.S. Business Unit, overseeing Takeda's U.S. commercial operations. The available context confirms her role and the company, but does not provide additional background such as education or prior positions.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pacheco Rhonda Janice profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.